Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery
- Status
- WITHDRAWN
- Phase
- PHASE2
Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.
- Status
- WITHDRAWN
- Phase
- PHASE1
Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy
- Status
- TERMINATED
- Phase
- PHASE1
Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab With or Without Surgery for Adult Glioblastomas
- Status
- WITHDRAWN
- Phase
- PHASE2
Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
HYPAZ: Hypertension Induced by Pazopanib
- Status
- TERMINATED
- Phase
- PHASE2
Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
BIBF 1120 for Recurrent High-Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE2
Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients
- Status
- COMPLETED
- Phase
- N/A
Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2